STAAR Surgical Profit Margin 2006-2021 | STAA

Current and historical gross margin, operating margin and net profit margin for STAAR Surgical (STAA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STAAR Surgical net profit margin as of June 30, 2021 is 10.08%.
STAAR Surgical Annual Profit Margins
STAAR Surgical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $6.795B $0.163B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $75.229B 19.74
Align Technology (ALGN) United States $56.840B 81.93
West Pharmaceutical Services (WST) United States $33.188B 64.09
Straumann Holding AG (SAUHF) Switzerland $32.360B 0.00
McKesson (MCK) United States $32.134B 10.38
Laboratory Of America Holdings (LH) United States $28.528B 8.73
AmerisourceBergen (ABC) United States $25.655B 14.09
Cooper (COO) United States $21.526B 33.28
Cardinal Health (CAH) United States $14.917B 9.47
DENTSPLY SIRONA (XRAY) United States $13.382B 20.62
Henry Schein (HSIC) United States $10.822B 17.69
Merit Medical Systems (MMSI) United States $4.032B 34.12
CONMED (CNMD) United States $3.792B 42.49
Patterson (PDCO) United States $3.015B 15.34
SmileDirectClub (SDC) United States $2.600B 0.00
Atrion (ATRI) United States $1.332B 42.71
Antares Pharma (ATRS) United States $0.636B 34.00
Retractable Technologies (RVP) United States $0.400B 7.79
Invacare (IVC) United States $0.205B 0.00
Vapor (HCMC) United States $0.204B 0.00
Milestone Scientific (MLSS) United States $0.135B 0.00
Biolase (BIOL) United States $0.104B 0.00
Pro-Dex (PDEX) United States $0.096B 23.57
Lifevantage (LFVN) United States $0.095B 6.86